{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:46:07Z","timestamp":1755798367100,"version":"3.44.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Leber\u2019s hereditary optic neuropathy (LHON) is a rare inherited mitochondrial disease caused by variants in mitochondrial DNA (mtDNA) transmitted exclusively through the maternal line. The disease predominantly affects young males and is characterized by progressive bilateral vision loss. Idebenone, a well-studied drug, modestly enhances the mitochondrial function and visual acuity in many patients with LHON. In this study, we report the case of a 48-year-old woman diagnosed with LHON (m.11778G&amp;gt;A\/<jats:italic>MT-ND4<\/jats:italic>) and type 2 diabetes mellitus who experienced visual field improvement following metformin treatment after 26\u202fmonths of progressive vision loss unresponsive to idebenone, nicotinamide adenine dinucleotide (NAD+), and hormone replacement therapy (HRT). Our findings offer an intriguing perspective on LHON management but require more investigations, particularly on the molecular effects of metformin on the mitochondrial function in LHON patients.<\/jats:p>","DOI":"10.3389\/fmed.2025.1609941","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T05:20:26Z","timestamp":1755580826000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin may alter the course of Leber\u2019s hereditary optic neuropathy: a case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Shenoda Abd","family":"Elmaseh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle A.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Golmohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nutsa","family":"Pargalava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo A.","family":"Sadun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1474-4422(22)00174-0","article-title":"Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management","volume":"22","author":"Newman","year":"2023","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2174\/1381612823666170125164856","article-title":"Treatment of Leber\u2019s hereditary optic neuropathy","volume":"23","author":"Sadun","year":"2017","journal-title":"Curr Pharm Des"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ophtha.2019.11.014","article-title":"Demographics of a large international population of patients affected by Leber\u2019s hereditary optic neuropathy","volume":"127","author":"Poincenot","year":"2020","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e2304884120","DOI":"10.1073\/pnas.2304884120","article-title":"Coenzyme Q10 trapping in mitochondrial complex I underlies Leber\u2019s hereditary optic neuropathy","volume":"120","author":"Fuller","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40265-020-01428-3","article-title":"Therapeutic options in hereditary optic neuropathies","volume":"81","author":"Amore","year":"2021","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in cancer treatment and prevention","volume":"66","author":"Morales","year":"2015","journal-title":"Annu Rev Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1463-1326.2010.01349.x","article-title":"Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials","volume":"13","author":"Lamanna","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1111\/dom.13362","article-title":"Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro","volume":"20","author":"Breining","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(13)70125-6","article-title":"Diabetes drugs and neurological disorders: new views and therapeutic possibilities","volume":"2","author":"Patrone","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"179412","DOI":"10.1155\/2011\/179412","article-title":"Leber\u2019s hereditary optic neuropathy-gene therapy: from benchtop to bedside","volume":"2011","author":"Koilkonda","year":"2011","journal-title":"J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.2147\/JIR.S436147","article-title":"The role and mechanism of metformin in inflammatory diseases","volume":"16","author":"Lin","year":"2023","journal-title":"J Inflamm Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.4239\/wjd.v15.i6.1178","article-title":"Metformin-associated lactic acidosis: a mini review of pathophysiology, diagnosis and management in critically ill patients","volume":"15","author":"See","year":"2024","journal-title":"World J Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fendo.2018.00753","article-title":"Metformin-induced mitochondrial complex I inhibition: facts, uncertainties, and consequences","volume":"9","author":"Fontaine","year":"2018","journal-title":"Front Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/1873-3468.14021","article-title":"Mitochondrial DNA copy number in human disease: the more the better?","volume":"595","author":"Filograna","year":"2021","journal-title":"FEBS Lett"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/brain\/awq276","article-title":"Oestrogens ameliorate mitochondrial dysfunction in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Giordano","year":"2011","journal-title":"Brain"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1093\/hmg\/ddv396","article-title":"Targeting estrogen receptor \u03b2 as preventive therapeutic strategy for Leber\u2019s hereditary optic neuropathy","volume":"24","author":"Pisano","year":"2015","journal-title":"Hum Mol Genet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1093\/brain\/awr192","article-title":"Treatment of Leber hereditary optic neuropathy","volume":"134","author":"Newman","year":"2011","journal-title":"Brain"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.tem.2019.07.015","article-title":"Metformin as anti-aging therapy: is it for everyone?","volume":"30","author":"Soukas","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/ph16121714","article-title":"Metformin: the winding path from understanding its molecular mechanisms to proving therapeutic benefits in neurodegenerative disorders","volume":"16","author":"Isop","year":"2023","journal-title":"Pharmaceuticals"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.brainres.2016.05.013","article-title":"Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice","volume":"1644","author":"Oliveira","year":"2016","journal-title":"Brain Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"102342","DOI":"10.1016\/j.redox.2022.102342","article-title":"Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients","volume":"53","author":"De Mara\u00f1\u00f3n","year":"2022","journal-title":"Redox Biol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.redox.2017.08.018","article-title":"Metformin selectively targets redox control of complex I energy transduction","volume":"14","author":"Cameron","year":"2018","journal-title":"Redox Biol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"9785890","DOI":"10.1155\/2016\/9785890","article-title":"Metformin decreases reactive oxygen species, enhances osteogenic properties of adipose-derived multipotent mesenchymal stem cells in vitro, and increases bone density in vivo","volume":"2016","author":"Marycz","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e15321","DOI":"10.1111\/j.1755-3768.2022.15321","article-title":"Mitochondrial optic neuropathies (MON)","volume":"100","author":"Sadun","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fendo.2019.00294","article-title":"Role of mitochondria in the mechanism(s) of action of metformin","volume":"10","author":"Vial","year":"2019","journal-title":"Front Endocrinol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10863-006-9003-8","article-title":"The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin","volume":"38","author":"Batandier","year":"2006","journal-title":"J Bioenerg Biomembr"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.bbadis.2015.01.006","article-title":"The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent","volume":"1852","author":"Chung","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1356703","DOI":"10.3389\/fnins.2024.1356703","article-title":"Mito-metformin protects against mitochondrial dysfunction and dopaminergic neuronal degeneration by activating upstream PKD1 signaling in cell culture and MitoPark animal models of Parkinson\u2019s disease","volume":"18","author":"Ay","year":"2024","journal-title":"Front Neurosci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","article-title":"AMPK: sensing glucose as well as cellular energy status","volume":"27","author":"Lin","year":"2018","journal-title":"Cell Metab"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"106114","DOI":"10.1016\/j.phrs.2022.106114","article-title":"Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications","volume":"177","author":"Feng","year":"2022","journal-title":"Pharmacol Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1042\/BJ20140620","article-title":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria","volume":"462","author":"Bridges","year":"2014","journal-title":"Biochem J"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s00125-017-4349-5","article-title":"Metformin and ageing: improving ageing outcomes beyond glycaemic control","volume":"60","author":"Valencia","year":"2017","journal-title":"Diabetologia"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/nyas.14141","article-title":"Metformin promotes mitophagy in mononuclear cells: a potential in vitro model for unraveling metformin\u2019s mechanism of action","volume":"1463","author":"Bhansali","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.biocel.2015.01.023","article-title":"Mitochondria: biogenesis and mitophagy balance in segregation and clonal expansion of mitochondrial DNA mutations","volume":"63","author":"Carelli","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2014.03.011","article-title":"Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation","volume":"19","author":"Mishra","year":"2014","journal-title":"Cell Metab"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2016.23","article-title":"Mitonuclear communication in homeostasis and stress","volume":"17","author":"Quir\u00f3s","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/brain\/awt343","article-title":"Efficient mitochondrial biogenesis drives incomplete penetrance in Leber\u2019s hereditary optic neuropathy","volume":"137","author":"Giordano","year":"2014","journal-title":"Brain"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1038\/s41467-020-17821-1","article-title":"Inhibition of autophagy curtails visual loss in a model of autosomal dominant optic atrophy","volume":"11","author":"Zaninello","year":"2020","journal-title":"Nat Commun"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"111286","DOI":"10.1016\/j.biopha.2021.111286","article-title":"The effects of metformin on autophagy","volume":"137","author":"Lu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"622262","DOI":"10.3389\/fphar.2021.622262","article-title":"Metformin: a novel weapon against inflammation","volume":"12","author":"Bai","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/ICU.0000000000000410","article-title":"Leber hereditary optic neuropathy: bridging the translational gap","volume":"28","author":"Jurkute","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/1440-1681.13073","article-title":"NF-\u03baB as the mediator of metformin\u2019s effect on ageing and ageing-related diseases","volume":"46","author":"Kanigur Sultuybek","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4161\/15548627.2014.984271","article-title":"Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway","volume":"11","author":"Song","year":"2015","journal-title":"Autophagy"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1609941\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T05:20:27Z","timestamp":1755580827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1609941\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":49,"alternative-id":["10.3389\/fmed.2025.1609941"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1609941","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"article-number":"1609941"}}